GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Aprea Therapeutics APRE · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.50

-3.21%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Aprea Therapeutics

Our reporting

We have not reported on Aprea Therapeutics yet.

Next results

15 Mar 2027

Due on 15 Mar 2027. Analysts expect earnings of -0.09 a share on revenue of $368,500.

Past results

Reported against what analysts expected

4 Nov 202612 Aug 202611 Aug 202613 May 202616 Mar 202612 Nov 2025
Earnings per share-0.09-0.07-0.53-0.22-0.32-0.47
Forecast-0.07-0.18-0.22-0.23-0.38-0.11
Revenue———$140,500$3,337$1,848
Forecast$307,500$253,000——$3,337—

Key events

  1. 13 Feb 202320-to-1 reverse split
  2. 3 Oct 2019Listed

Aprea Therapeutics in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.